Scholars Central

Took place22nd editionDiabetes & Endocrinology

22nd International Conference on Prevention of Diabetes and Complications

When
Oct 12–13, 2017

Programme

21 sessions

21 sessions

Keynote Forum · Thursday Oct 12, 201709:30–11:55

  1. Why clinical trials show that strict glucose regulation does not prevent diabetic complications in T2D: Evidence supporting an alternative hypothesis for pathogenesisDouglas N Ishii · 09:30–10:10
  2. Integrating diabetes care to improve diabetes care across the community- experience from North East EssexVithian Karunakaran · 10:10–10:50
  3. If glucose is not eukaryote cell power source, how understand diabetes mellitus?Arturo Solis Herrera · 11:15–11:55

Sessions · Thursday Oct 12, 201711:55–12:25 · Bleriot 2

  1. Cardiometabolic syndrome and increased risk of heart failureHelene von Bibra · 11:55–12:25 · Bleriot 2
  2. The effect of 6 weeks exercise program in prediabetic and metabolic syndrome individualsBandar Manawer Alharbi · Bleriot 2
  3. Prediction of anti-diabetic activity of flavonoids targeting α-glucosidaseMarisa Freitas · Bleriot 2
  4. HbA1c screening for new onset diabetes following acute coronary syndrome: Is it a worthwhile test in clinical practice?Parijat De · Bleriot 2
  5. A novel botanical formula prevents diabetes by improving insulin resistanceJuntao Kan · Bleriot 2
  6. Polyuria is the cause of long term diabetes complicationsOwusu Akyiaw Bempah · Bleriot 2
  7. Role of Nigella sativa oil and antidiabetic drugs in modifying the brain insulin signaling in Streptozotocin-induced diabetic ratsMahmoud Balbaa · Bleriot 2
  8. Analysis of chosen polymorphisms rs2476601 A/G - PTPN22, rs20541 A/G – IL13 rs29941 A/G – KCTD15 in pathogenesis of type 1 diabetes in childrenArtur Bossowski · Bleriot 2
  9. Impact of nutritional access on obesity and diabetes: “Food Swamps” and “Food Deserts”Don S Schalch · Bleriot 2

Keynote Forum · Friday Oct 13, 201709:30–11:50

  1. The problems of vitamin D and metabolic syndrome: How might varying status affect risks of its component disorders, and at what stage of risk development?Barbara Boucher · 09:30–10:10
  2. POWER2DM: Predictive model-based decision support for diabetes patient empowermentAlbert de Graaf · 10:10–10:50
  3. Regulation of peripheral glucose uptake by regulating GLUT4 endocytosisNing Wu · 11:10–11:50

Sessions · Friday Oct 13, 201714:40–16:30 · Bleriot 2

  1. Does the olive-derived polyphenol oleuropein affect postprandial glycaemic response following a short term high fat intake: Randomised, double-blinded, placebocontrolled, crossover trialArmin Ezzati · 14:40–15:10 · Bleriot 2
  2. Structure-related inhibition of Protein Tyrosine Phosphatase 1B (PTP1B) by flavonoidsCarina Proença · 15:30–16:00 · Bleriot 2
  3. Possible attenuating influence of M. Charantia in diabetic nephropathy following triplavar: Any glimmer of hope?Ugochukwu Offor · 16:00–16:30 · Bleriot 2
  4. Type 2 diabetes mellitus in the Czech Republic: Prediction of prevalence and costsJana Votapkova · Bleriot 2
  5. A retrospective study to determine the prevalence of hyperuricemia in Indian subjects attending hyperuricemia screening campsGauri Billa · Bleriot 2
  6. Type 2 diabetes and obesity and its correlates in a first nationwide study among Cypriot adultsEleni Andreou · Bleriot 2

Recap

21 abstracts presented at this edition, linked from the programme.

Talks and sessions
21
Days
2
Tracks
3
Abstracts held here
21

Thursday Oct 12, 2017 – Friday Oct 13, 2017

Tracks, and how many items each carried

  • Technologies for the Treatment of Diabetes | Diabetes Associated Disorders Diabetes and its Complications | Genesis of Diabetes | Screening of Diabetes9
  • Computerised Applications in Diabetes | Diabetes Education and its Risk Factors | Emerging Focus in the Treatment of Diabetes | Gestational Diabetes6
  • Keynote Forum6

Keynotes and plenaries, as the programme printed them

  • Why clinical trials show that strict glucose regulation does not prevent diabetic complications in T2D: Evidence supporting an alternative hypothesis for pathogenesisDouglas N Ishii
  • Integrating diabetes care to improve diabetes care across the community- experience from North East EssexVithian Karunakaran
  • If glucose is not eukaryote cell power source, how understand diabetes mellitus?Arturo Solis Herrera
  • The problems of vitamin D and metabolic syndrome: How might varying status affect risks of its component disorders, and at what stage of risk development?Barbara Boucher
  • POWER2DM: Predictive model-based decision support for diabetes patient empowermentAlbert de Graaf
  • Regulation of peripheral glucose uptake by regulating GLUT4 endocytosisNing Wu

Names as printed in the programme. Scholars Central adds no affiliation to them.

No session summary has been checked for this event yet.

What this programme does not say
  • The programme does not say how many people attended, and Scholars Central keeps no record of who attended.
  • Nothing here comes from a recording, a transcript or the discussion in the room: there are none.

A programme is published for about one past event in five, so a digest is not available for every event.

Website and contact

Sponsor, exhibit or ask

This edition has ended. You can still send the organisers a question.

Something wrong on this page?

Tell the Scholars Central team about a wrong date or place, a broken link, or anything else.

Journals and research